-
Product Insights
New![]()
Net Present Value Model: Enanta Pharmaceuticals Inc’s EDP-305
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Enanta Pharmaceuticals Inc’s EDP-938
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.Drug Operating Profit Model
-
Product Insights
New![]()
Net Present Value Model: Evelo Biosciences Inc’s EDP-1815
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Enanta Pharmaceuticals Inc’s EDP-514
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.Drug Operating Profit Model
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-2939 in Skin Inflammation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EDP-2939 in Skin Inflammation Drug Details: EDP-2939 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-1815 in Skin Inflammation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EDP-1815 in Skin Inflammation Drug Details: EDP-1815 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-297 in Non-Alcoholic Steatohepatitis (NASH)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EDP-297 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:EDP-297 is under development for the treatment of non-alcoholic steatohepatitis (NASH)....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-2939 in Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. EDP-2939 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: EDP-2939 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-1815 in Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EDP-1815 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: EDP-1815 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-323 in Respiratory Syncytial Virus (RSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EDP-323 in Respiratory Syncytial Virus (RSV) Infections Drug Details:EDP-323 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EDP-938 in Respiratory Syncytial Virus (RSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EDP-938 in Respiratory Syncytial Virus (RSV) Infections Drug Details:EP-938 is under development for the treatment of...
-
Product Insights
EDP Brasil – Wind Power Complex 124 MW – Paraiba
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Brasil - Wind Power Complex 124 MW - Paraiba report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
EDP Renewables North America – Cattlemen Solar Farm 240 MW – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Renewables North America - Cattlemen Solar Farm 240 MW - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
EDP Renewables North America – Milam County Solar Plant 240MV – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Renewables North America - Milam County Solar Plant 240MV - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
EDP Ren Canada/ Ellaktor – Evia Wind Farm 470 MW – Greece
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Ren Canada/ Ellaktor - Evia Wind Farm 470 MW - Greece report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
EDP Renewables North America – Randolph Solar Farm 200 MW – Arizona
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Renewables North America - Randolph Solar Farm 200 MW - Arizona report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
EDP Brasil – Serra da Borborema Wind Complex 280.5 MW – Paraiba
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Brasil - Serra da Borborema Wind Complex 280.5 MW - Paraiba report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
EDP Renewables – Beaumont-Sivry-Rance Wind Farm 42 MW – Wallonia
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Renewables - Beaumont-Sivry-Rance Wind Farm 42 MW - Wallonia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
EDP Ren Canada – Blue Bridge Solar PV Park 150 MW – Alberta
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Ren Canada - Blue Bridge Solar PV Park 150 MW - Alberta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
EDP Renewables North America – Timber Road Solar farm 49.9 MW – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our EDP Renewables North America - Timber Road Solar farm 49.9 MW - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.